Home > Healthcare > Medical Devices > Diagnostic Devices > Helicobacter Pylori Testing Market
Helicobacter Pylori Testing Market size was valued at over USD 447 million in 2022. Driven by the increasing instances of peptic ulcers, the market is slated to register over 6.5% CAGR from 2023 to 2032.
People infected with helicobacter pylori are prone to gastric ulcers as the bacteria can damage the inner protective lining of their intestine as well as stomach. Based on that co-relation, growing cases of gastric ulcers across the globe are primarily fueling the demand for helicobacter pylori testing.
Helicobacter pylori infection is typically diagnosed through an invasive procedure, which entails biopsy and endoscopy, and requires advanced operational skills for precisely diagnosing and identifying the appropriate treatment method. However, the lack of trained professionals in nations with limited healthcare resources may affect the disease testing rates, dampening the market progress. Many low and middle-income economies lack the hospital and medical training infrastructure needed to highly skilled physicians. Helicobacter pylori treatment also poses other challenges for physicians as no first-line therapy can treat the infection for all patients.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Helicobacter Pylori Testing Market Size in 2022: | USD 447 million |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 6.5% |
2032 Value Projection: | USD 876 million |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 204 |
Tables, Charts & Figures: | 337 |
Segments covered: | Test Type, Method, End-use, and Region. |
Growth Drivers: |
|
Pitfalls & Challenges: |
|